SQSTM1 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Muscles from dysferlinopathy patients show elevated MuRF-1, LC3-II, p62/SQSTM1 and Bnip3 levels, and fiber atrophy phenotypically.